Compare Gilead Sciences, Inc. (GILD) vs STMicroelectronics NV (STM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs STMicroelectronics NV — how do they compare? Gilead Sciences, Inc. trades at $147 (market cap $182.09B), while STMicroelectronics NV trades at $53.95 (market cap $50.29B). The key difference: Gilead Sciences, Inc. is far larger — about 3.6× STMicroelectronics NV's market cap, and Gilead Sciences, Inc. pays the higher dividend (2.23%). Which is the better fit depends on your goals — on Pluang, investors hold Gilead Sciences, Inc. for 111 Days and STMicroelectronics NV for 66 Days on average.
| GILD | STM | |
|---|---|---|
Market Cap | $182.09B | $50.29B |
Volume | 4,960,247 | 9,536,788 |
Sector | Health | Technology |
52-Week High | $155.80 | $79.91 |
52-Week Low | $116.74 | $21.20 |
Typical Hold Time | 111 Days | 66 Days |
Enterprise Value | $205.15B | $47.81B |
Dividend Yield | 2.23% | 0.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $146.85, up 1.82% with bullish technical signals and strong analyst support. Recent earnings beat expectations in three consecutive quarters, though Q2 showed a significant loss. The company maintains robust operating cash flow of $10.02B (2025) and expanded HIV prevention access through a major PAHO partnership. Valuation metrics show a P/E of 17.84 and P/S of 6.02, with revenue growth from $29.44B (2025) to projected $30.5B (2026).
Outlook remains positive with 65% analyst buy ratings and $151.57 consensus target, though risks include negative net income margin (-10.64%) and high debt levels. The stock offers dividend income ($0.82 upcoming) and pipeline catalysts in oncology/HIV, but investors should monitor earnings volatility and competitive pressures in biopharma.
STM (STMicroelectronics) trades at $52.71, down 10.24% in the last session. The stock shows a bullish technical signal with moving averages supporting an uptrend, though oscillators are neutral. Fundamentally, revenue declined to $11.80B in 2025 with a net income margin of -0.39%, but recent Q2 2026 earnings beat expectations. Analyst sentiment is positive with a consensus price target of $77.31. Recent news highlights recovery in automotive and industrial demand, with AI data-center revenue projected to exceed $2B by 2027.
The outlook for STM hinges on execution in AI and automotive segments, offering growth potential, but risks include margin pressures from fab transitions and competitive threats. Wall Street's buy rating majority (51.72%) reflects optimism, though investors should monitor earnings consistency and debt levels, with the stock trading below consensus target indicating potential upside if recovery sustains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →
